stars 1 stars 2 stars 3

BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).

BioCytics Inc Questions

The BioCytics Inc annual revenue was $8 million in 2026.

Jim Powderly is the Co-Founder and Strategic Development of BioCytics Inc.

13 people are employed at BioCytics Inc.

BioCytics Inc is based in Huntersville, North Carolina.

The NAICS codes for BioCytics Inc are [62151, 62, 6215, 621].

The SIC codes for BioCytics Inc are [807, 80].

Top BioCytics Inc Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users